#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant fibrous histiocytoma Retinoblastoma B precursor type acute leukaemia Acute myeloid leukaemia recurrent Dementia with Lewy bodies Alveolar proteinosis Waldenstrom's macroglobulinaemia Immune-mediated myasthenia gravis Complex regional pain syndrome Vitamin B12 deficiency Haemolytic uraemic syndrome Myelodysplastic syndrome with excess blasts Alexander disease Fms-like tyrosine kinase 3 positive Multiple system atrophy More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Trials in Disease Uterine leiomyosarcoma – Life with Disease Activated PI3 kinase delta syndrome Von Willebrand’s disease – Life with Disease Chondrosarcoma metastatic Chordoma – Life with Disease Hereditary hypophosphataemic rickets – Treatment Leukoencephalopathy – Basic Information Optic glioma – Trials in Disease Alternating hemiplegia of childhood – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Crofelemer Serpina1(Human)-Aav8-1 Rizolipase Cd7-Cart01 Belinostat SELTOREXANT BENZYLPENICILLIN POTASSIUM HYDROXYCHLOROQUINE Cariprazine Hydrochloride Irbesartan 1,3-BUTYLENE GLYCOL Nivolumab APAZUNERSEN Abc-23B-116 Valganciclovir Hydrochloride LY4170156 Ethanol, Anhydrous Peppermint Oil Al8326 Rilpivirine More therapies…

    Learn about Your Condition

    Rhinitis allergic Pneumococcal infection Schizophrenia Colon cancer stage IV Endometrial cancer Type 1 diabetes mellitus Urinary incontinence Spondylolisthesis Foetal growth restriction Cutibacterium acnes infection Peripheral spondyloarthritis HER2 negative breast cancer Eosinophilic gastritis Retroperitoneal cancer Hodgkin's disease recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Comparing human normal immunoglobulin (iv) and a drug combination to prevent infections in adults with B-cell acute lymphoblastic leukemia or B-cell lymphoma treated with CAR-T cells

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    • B-cell lymphoma
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Azithromycin
    • Levofloxacin
    France

  • Efficacy and Safety of Clemastine Fumarate in Children and Adults with Pitt‑Hopkins Syndrome: A Randomized Placebo‑Controlled Trial

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Clemastine Fumarate
    The Netherlands

  • A study to evaluate the safety and effectiveness of BMS-986523 alone or in combination with a drug combination for patients with advanced solid tumors and KRAS alterations.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Spain

  • Study of the efficacy and safety of ladarixin and rabbit anti-human thymocyte immunoglobulin in adolescents and adults with new-onset type 1 diabetes

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Ladarixin
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    Italy

  • A study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Belgium Italy The Netherlands Norway

  • A study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.

    Not yet recruiting

    3 1
    Investigated Drugs:
    • VORMATRIGINE
    Czechia Germany Italy Poland Spain
Previous Page
1 … 723 724 725 726 727 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!